Final overall survival (OS) analysis of the randomized phase 3 study of trabectedin (T) or dacarbazine (D) for the treatment of patients (pts) with...

Date 26 September 2015
Event European Cancer Congress 2015
Session Sarcoma: Soft Tissue and Bone
Topics Sarcoma
Presenter Patel, S.